We have recently shown that expression of a constitutively active Akt, or an increased activity of the human epidermal growth factor receptor-2 (HER2)/PI3-K/Akt or Ras/PI3-K/Akt pathway, leads to multidrug or radiation resistance in human breast cancer cells [16-18]. The gene discussed is ERBB2; the disease is breast cancer.